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ABSTRACT 
Self-microemulsifying drug delivery system (SMEDDS) is one approach for optimizing solubility and consequently the oral 
bioavailability of class 2 drugs in the biopharmaceutical classification system such as diclofenac which exhibit low aqueous 
solubility but high lipid permeability. The purpose of this study was to formulate self-microemulsifying drug delivery system 
based on coconut oil for the delivery of diclofenac, a hydrophobic non-steroidal anti-inflammatory drug (NSAID). Coconut oil 
was extracted and used in combination with tween 80, polyethylene glycol 400 (PEG400) and propylene glycol at varying ratios 
for the formulation of diclofenac-loaded solid self-microemulsifying drug delivery system (DCF-loaded solid SMEDDS) which 
were encapsulated in hard gelatin capsules and evaluated for drug content, emulsification time and in vitro drug release. The 
results from the study revealed that over 80 % of diclofenac was released from the SMEDDS within 30 minutes and percentage 
drug content was above 90 % except for BF3, BF5, and BF6 which were 87 %. Emulsification time for all the batches except 
BF6 were within 120 sec (2 min). It can be concluded that coconut oil in combination with polyethylene glycol 400 (PEG-400) 
and tween 80 could be used in the formulation of SMEDDS for the delivery of diclofenac for dissolution optimization. 
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INTRODUCTION 
  
Drugs belonging to class II of the biopharmaceutics 
classification system (BCS) have poor aqueous solubility and 
dissolution which result in sub-optimal bioavailability after 
oral administration of such drugs. Diclofenac sodium, a non-
steroidal anti-inflammatory drug belongs to class II of the 
biopharmaceutics classification system. One of the major 
problems with this class of drug is low aqueous solubility in 
biological fluids, which results in poor bioavailability after 
oral administration. The solubility of diclofenac in aqueous 
medium is about 0.078 mg/ml. Thus, increasing aqueous 
solubility and dissolution of diclofenac is of therapeutic value 
(Kausalya et al., 2011; Bhagwat and D’Souza, 2012). Self-
micro emulsifying drug delivery system (SMEDDS) is one 
approach for improving solubility and consequently the oral 
bioavailability of drugs in this class. 
SMEDDS are usually prepared in a liquid dosage form that 
can be administered in soft gelatin capsules, however this 
dosage form has some disadvantages particularly in the 
manufacturing process as well as possible incompatibility 
problems with the shells of soft gelatin. Solid SMEDDS have 
recently been formulated and were found to overcome the 
disadvantages of liquid SMEDDS as well as exhibit more 
commercial potential and patient acceptability (Akter and 
Hossain, 2012).   
 A major challenge in the oral delivery of lipophilic drugs 
is low aqueous solubility. Self-micro-emulsifying drug 
delivery systems (SMEDDS) have the ability to improve 
solubility and optimize bioavailability of drugs with poor 
aqueous solubility. Self-micro emulsifying drug delivery 
systems are isotropic mixtures of oil, surfactant, co-surfactant 
or co-solvents and can be used for the design of formulations 
in order to improve the oral absorption of highly lipophilic 
drugs. Self-microemulsifying drug delivery system can be 
administered orally in the form of hard or soft gelatin capsule 
and form fine stable oil-in-water (o/w) emulsion on aqueous 
dilution resulting from the gentle agitation of gastrointestinal 
fluid.  
  The process of self-emulsification of SMEDDS depends 
on a number of factors such as the type and ratios of oil and 
surfactant pair, the concentration of surfactant as well as the 
temperature at which self-emulsification occurs. The primary 
step in the formulation of a SMEDDS is the identification of 
these specific combinations of excipients and the construction 
of a ternary phase plot which shows various concentrations of 
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Water Smix (Tween 80/PRG 
The incorporation of an active pharmaceutical ingredient to a 
SMEDDS is critical because the drug interferes with the self-
emulsification process to a certain extent, which may lead to a 
change in the optimal oil–surfactant ratio. So, the design of an 
optimal SMEDDS requires preformulation solubility and 
phase-diagram studies. In the case of controlled release 
SMEDDS, formulation is made by adding a release retarding 
agent such as polymer or gelling agent (Nazzal and Khan, 
2006).  
 The aim of the study therefore was to evaluate the effect 
of coconut oil on the self-emulsifying properties of diclofenac 
loaded solid self-emulsifying drug delivery system. 
    
 
MATERIALS AND METHODS 
 
Materials: Diclofenac sodium was procured from Sigma 
chemical Co. (NJ, USA), Tween 80 (BDH chemical, Poole, 
England), Polyethylene glycol (BDH chemical, Poole, 
England), Propylene glycol (Manali Petrochemicals, India), 
Lactose (Loba Chemie, Mumbai, India ), and Talc (Loba 
Chemie, Mumbai, India ). Coconut oil was freshly prepared in 
the laboratory. 
 
Extraction of coconut oil from Cocos nucifera: Fruits of 
coconut were procured from a local market in Abraka, Delta 
State, Nigeria and their pericarps which consist of epicarp, 
mesocarp and endocarp were removed. The coconut seeds 
were sliced into small sizes using a grater. The size-reduced 
coconut was soaked in 1000 ml of distilled water for 30 
minutes. The solution was filtered using muslin bags in order 
to remove the chaff. The filtered solution was left overnight in 
the refrigerator. Thereafter, the coagulated interphase of the 
solution was heated using a heating mantle until the water 
evaporated thereby leaving the oil. The oil obtained was stored 
for evaluation and further use. 
 
Characterization of Cocos nucifera (coconut) oil 
 
Determination of Specific gravity: This was done using the 
specific gravity bottle. The bottle was first rinsed with distilled 
water, and dried in oven for 15 minutes, cooled, stoppered 
with a cap and weighed. The same specific gravity bottle was 
filled with the coconut oil sample, closed and again weighed. 
The weight of sample per ml was determined by subtracting 
the initial weight from the final weight. 
 
Determination of Refractive index: This was performed using 
a Refractometer (ABBE model) as described by a previous 
researcher (Kirk and Sawyer, 1991). Refractive index is 
specific for oils, within certain limits. It is related to the degree 
of binding / bonding saturation, but it is affected by other 
factors such as free fatty acids content, oxidation, and thermal 
treatment. 
 
Determination of pH: This was done using a pH/ORP meter, 
model HI 2211 (Hanna Instrument) at a temperature of 25°C 
± 2°C.  
 
Pseudo-ternary phase diagram construction: Pseudo-
ternary phase diagram of oil, surfactant, and co-surfactant was 
constructed using the water titration method at 25 ± 2°C. 
Coconut oil was combined with surfactant mix, Smix 
(containing surfactant and co-surfactant) in ratios of 9 : 1, 8 : 
2, 7 : 3, 6 : 4, 5 : 5, 4 : 6, 3 : 7, 2 : 8, 1 : 9 w/w in a glass vial 
for 5 minutes. Each ratio of oil and Smix was then titrated with 
distilled water in increments of 0.5% w/w of water, and the 
sample was mixed vigorously for at least 2 min and then kept 
at 25ᴼC for 10 min to equilibrate before next addition of water. 
The process was repeated until the sample turned turbid or 
until 90.9% w/w addition of water. The phase behaviour of 
each ternary phase system was observed during the titration. 
Samples with clear or slightly bluish appearance were taken 
as micro emulsion region. The percentage composition of each 
component in the ternary system was determined, and the 
results were plotted on the triangular coordinates to construct 
the phase diagram using Prosim® F-31312 (Ternary diagram 
software, Labege Cedex, France).  
 The concentration of oil, surfactant and co-surfactant that 
gave clear emulsions were selected as the self micro emulsions 
for the formulation of the Diclofenac SMEDDS and were 
labelled as BF1, BF2, BF3, BF4, BF5, and BF6 (Borhade et 
al., 2008; Ahmad et al., 2013; Syed and Peh, 2014. 
 
Table 1:  
Composition of selected self-micro emulsion of Oil, 
Surfactant and co-surfactant 
 
Batch 
                            Composition (% v/v) 
Coconut oil Tween 80 PEG 400 
BF1 35 20 20 
BF2 32 20 23 
BF3 40 20 20 
BF4 30 25 20 
BF5 20 20 30 





Figure 1:  
Pseudoternary phase diagram showing the microemulsion 
region (shaded region) 
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Table 2:  
Composition of DCF-loaded solid SMEDDS based on coconut oil 
Ingredients (g) 
Batch Coconut 0il  Tween 80  PEG400 propylene glycol  Diclofenac sodium Lactose Talc Total 
BF1 0.332 0.216 0.228 0.281 2.0 6.84 0.1 10 
BF2 0.295 0.216 0.262 0.281 2.0 6.85 0.1 10 
BF3 0.3682 0.216 0.228 0.225 2.0 6.86 0.1 10 
BF4 0.2762 0.27 0.228 0.281 2.0 6.84 0.1 10 
BF5 0.1841 0.216 0.338 0.338 2.0 6.82 0.1 10 
BF6 0.2300 0.2700 0.285 0.281 2.0 6.83 0.1 10 
 (Batch size: 20 capsules) 
 
Evaluation of Self micro emulsions: The selected 
concentrations of oil, surfactant and co- surfactant that 
produced self micro emulsion (SME) labelled BF1 to BF6 
were evaluated for pH, viscosity, conductivity and refractive 
index (Porter et al., 2007).  
Viscosity: Viscosity of the different SMEs were measured at 
25°C using a NDJ-8S digital viscometer (Shanghai Precision 
and Scientific Instrument, Shanghai, China) with a No 1 
spindle at 60 rpm.  
Conductivity: Electrical conductivity was determined using a 
conductivity meter (DDS-11C, Shanghai San-Xin 
Instrumentation Inc, Shanghai, China) 
Refractive Index: Refractive index measurement was done 
with Abbe Refractometer (Shijiazhuang Optical Instrument 
Factory, Xiamen, China). 
pH: The pH measurement was carried out using a pH/ORP 
meter, model HI 2211 (Hanna Instruments) at a temperature 
of 25°C ± 2°C. 
 
Preparation and encapsulation of DCF-loaded solid 
SMEDDS granules: The preparation of diclofenac SMEDDS 
batch formulation was done according to the quantities stated 
in Tables 2. In each case, weighed amounts of coconut oil, 
surfactants (tween 80), co-surfactant (PEG400) and co-solvent 
(propylene glycol) were mixed manually with stirring for 5 
min in a beaker over a water bath at 500C. A 2 g quantity of 
diclofenac sodium (equivalent to 20 capsules, each holding 
100 mg) was weighed and dissolved in the SME. After which 
lactose (solid carrier) was added and was properly mixed to 
form a wet mass.  The wet mass was sieved using 800µm 
sieve. The granules were dried and dry sieving was done using 
600 µm sieve, and then dried again in an oven 600C. Talc was 
added to the dried granules. 
Encapsulation of the SMEDDSs from the different batches 
was done by weighing quantities equivalent 100 mg of 
diclofenac into a 500 mg capacity hard gelatin capsule. The 
batch size for diclofenac-loaded SMEDDS was twenty (20) 
capsules each containing exactly 100 mg diclofenac. 
 
Micromeritic properties of DCF-loaded solid SMEDDS 
granules  
Angle of repose: Diclofenac-loaded SMEDDS granule 
equivalent to 8 g was weighed and allowed to fall freely from 
a funnel clamped to a retort stand at a height of 7.5 cm from a 
horizontal surface. The diameter and the height of the pile 
formed by the granules were measured using a meter rule. This 
procedure was also repeated in triplicate for each batch and 
the result was recorded (Chawla et al., 2003).  
 
𝐴𝑛𝑔𝑙𝑒 𝑜𝑓 𝑟𝑒𝑝𝑜𝑠𝑒 (Ѳ) =  𝑡𝑎𝑛 − ¹ (
ℎ
𝑟
)                  (1)                      
Where,   = height of the pile, 𝑟  = radius of the base of the 
pile,   = angle of repose. 
 
Bulk and tapped densities: An 8g quantity of granules from 
each batch was weighed and packed into a 20 ml graduated 
cylinder. The granules were carefully levelled without 
compacting and the unconsolidated apparent volume (Vo) was 
read and recorded as the bulk volume. Thereafter, the cylinder 
was tapped to constant volume and recorded as the final 
tapped volume (Vf). The process was done in triplicate and 
then the bulk density and tapped density in g/ml were 




                  (2)    
𝑇𝑎𝑝𝑝𝑒𝑑 𝑑𝑒𝑛𝑠𝑖𝑡𝑦 =  
𝑀
𝑉𝑓
                   (3) 
Where, 𝑀 = mass of the powder, 𝑉0= bulk or unconsolidated 
apparent volume of the powder 
𝑉𝑓= final tapped volume of the powder 
 
Compressibility index (Carr’s index) and Hausner ratio: The 
Compressibility index and Hausner ratio of the granules were 




𝑇𝑎𝑝𝑝𝑒𝑑 𝑑𝑒𝑛𝑠𝑖𝑡𝑦 − 𝐵𝑢𝑙𝑘 𝑑𝑒𝑛𝑠𝑖𝑡𝑦
𝑇𝑎𝑝𝑝𝑒𝑑 𝑑𝑒𝑛𝑠𝑖𝑡𝑦
∗ 100                (4) 
 
𝐻𝑎𝑢𝑠𝑛𝑒𝑟 𝑟𝑎𝑡𝑖𝑜 =  
𝑇𝑎𝑝𝑝𝑒𝑑 𝑑𝑒𝑛𝑠𝑖𝑡𝑦
𝐵𝑢𝑙𝑘 𝑑𝑒𝑛𝑠𝑖𝑡𝑦
                  (5) 
 
Estimation of diclofenac content 
Drug content in solid SMEDDS was determined. Accurately 
weighed diclofenac-loaded solid SMEDDS, equivalent to 100 
mg diclofenac, was thoroughly dissolved in 100 ml of 
phosphate buffer, pH 6.8 in a volumetric flask. The solution 
was filtered using a 0.45 μm filter paper and assayed for 
diclofenac content at 276 nm using Shimadzu UV-1601 
spectrophotometer. The drug content (%) was estimated by the 
following formula:  
Diclofenac- loaded solid self-emulsifying drug delivery system 
184 Afr. J. Biomed. Res. Vol. 24, No.2 (May) 2021  Alalor et al 
 
𝐷𝐶 =  
𝐶𝑝
𝐶𝑡  
 ∗ 100                     (6)     
 
Where DC is the percentage of drug content, Cp is the 
concentration determined by UV Spectrophotometer, and Ct is 
the theoretical concentration. 
 
 
Dissolution test: In vitro dissolution test was performed using 
dissolution tester (Erweka apparatus – type: DT, Nr: 56263, 
Germany), USP dissolution apparatus 1 rotating at 100 rpm in 
900 ml phosphate buffer of pH 6.8 at 37 ± 0.5ºC. Aliquot of 
dissolution medium equal to 5 ml was withdrawn at specified 
time intervals and replaced with same volume of fresh 
dissolution medium. The withdrawn samples were diluted 
accordingly and the concentration of diclofenac was 
determined spectrophotometrically using Shimadzu UV-
1601, Japan at a wave length of maximum absorption of 276 
nm by using the regression equation from the standard 
calibration curve. 
 
Emulsification time: The content of one capsule randomly 
drawn from each batch was emptied into a beaker containing 
250 ml of distilled water with little agitation of the mixture. 




RESULTS AND DISCUSSION  
The result of the physicochemical evaluation of coconut oil as 
presented in Table 2 shows that coconut oil with specific 
gravity of 0.9205 is not as dense as water; while the refractive 
index value of 1.5609 shows that the extracted coconut oil is 
not as transparent as water (1.333). 
 
Table 2:  
Physicochemical characteristics of extracted Cocos nucifera 
(coconut) oil 
Parameters Values 
Specific gravity 0.9205 
Refractive index (28.5 °C) 1.5609 
pH 6.2 
 
Table 3:  
Physiochemical characterizations of SMEDDS 







BF1 6.4 3000 1.74 1.9543  
BF2 6.3 3500 1.22 1.5609  
BF3 6.45 3500 1.84 1.5598  
BF4 6.99 250 1.21 1.6051  
BF5 6.10 300 1.15 1.5944  
BF6 6.30 350 1.06 1.5922  
 
Refractive index of diluted SMEDDS was found to be in the 
range of 1.559 – 1.954. Electrical conductivity was carried out 
to differentiate between the water-in-oil (w/o), bi continuous 
or oil-in-water (o/w) micro emulsion. Electrical 
conductivity is a function of the water content (% w/w) 
for self-micro emulsifying drug delivery systems (SMEDDS). 
The conductivity as revealed in Table 3 is in the range of 1.06 
-1.84 which is quite low 
 
 
Figure 2:  




The self-emulsification efficiency could be primarily 
estimated by an assessment the rate of emulsification which is 
an important index for the determination of the efficiency of 
emulsification, that is, SMEDDS should disperse completely 
and quickly when subjected to aqueous dilution under mild 
agitation. Emulsification time for all the batches were within 
120 sec (2 min) except for batch BF6 as revealed in Figure 2. 
Batches BF1 and BF4 showed higher self-emulsification 
efficiency with the lowest emulsification time of 90 seconds 
apiece. 
 The results of the micromeritic characterization presented 
in Table 4 reveal that the tapped densities of the granules were 
greater than their bulk densities. The angle of repose for BF1 
to BF6 ranged from 30-350. This falls into the range of good 
flow property based on angle of repose (Carr, 1965). Batch 
BF5 gave the best angle of repose value of 30.90 followed by 
BF6 (33.60) and BF1 (33.80).  
 The compressibility index and Hausner ratio are measures 
of the ease or tendency of a powder to be compressed as well 
as interparticulate interactions and from the results in Table 4, 
the values of the Carr’s index and Hausner ratio are in the 
range of 34.7 – 43.13% and 1.53-1.76 respectively which are 
rather too large and would result in granules being poorly 
compressible, although these granules are meant to be filled 
into hard gelatin capsules. However, the suboptimal values of 
Carr’s index and Hausner ratio will also affect the flowability 
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Table 4:   
Micromeritic characterization of diclofenac- loaded SMEDDS granules 




Bulk density (g/ml) Hausner ratio   Car’s index (%) 
BF1 33.8 ± 0.95 0.73 ± 0.07 0.427 ± 0.01 1.6 ± 0.10 41.3 ± 0.65 
BF2 35.1 ± 1.04 0.73 ± 0.06 0.43 ± 010 1.69±0.15 40.5 ± 0.56 
BF3 35.6 ± 1.35 0.75 ± 0.04 0.427 ± 0.01 1.76±0.12 43.13 ± 0.39 
BF4 35.1 ± 1.27 0.73 ± 0.00 0.421 ± 0.00 1.73±0.00 42.6 ± 0.32 
BF5 30.9 ± 1.20 0.68 ± 0.05 0.440 ± 0.00 1.53±+0.1 34.7 ± 4.70 




Figure 3:  
Drug contents of the various batches of coconut oil based 
diclofenac-loaded solid SMEDDS 
 
 
Figure 4:  
Release profile of coconut oil based diclofenac-loaded 
SMEDDS for batches  
BFI ♦, BF2 ■ and BF3 ▲ 
 
The results of the micromeritic characterization presented in 
Table 4 reveal that the tapped densities of the granules were 
greater than their bulk densities. The angle of repose for BF1 
to BF6 ranged from 30-350. This falls into the range of good 
flow property based on angle of repose (Carr, 1965). Batch 
BF5 gave the best angle of repose value of 30.90 followed by 
BF6 (33.60) and BF1 (33.80).  
 The compressibility index and Hausner ratio are measures 
of the ease or tendency of a powder to be compressed as well 
as interparticulate interactions and from the results in Table 4, 
the values of the Carr’s index and Hausner ratio are in the 
range of 34.7 – 43.13% and 1.53-1.76 respectively which are 
rather too large and would result in granules being poorly 
compressible, although these granules are meant to be filled 
into hard gelatin capsules. However the suboptimal values of 
Carr’s index and Hausner ratio will also affect the flowability 
of the granules.  
 
    
Figure 5:  
Release profile of coconut oil based diclofenac-loaded SMEDDS for 
batches  
BF4 ♦, BF5 ■ and BF6 ▲ 
 
 British Pharmacopoeia specification for content 
uniformity is 85 to 115% of the labelled claim (B.P., 2013). 
The Percentage drug contents of diclofenac-loaded SMEDDS  
batches BF1, BF2, BF3, BF4, BF5 and BF6 were 93%, 92.3%, 
87%, 95%, 87% and 87% respectively as presented in Fig. 3. 
From the result obtained it can be said that all the batches met 
the B.P specification for content uniformity with batch BF4 
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 The results of the dissolution profile of all batches of 
diclofenac-loaded SMEDDS are presented in Figures 4 and 5. 
All batches were able to release 80% or more of diclofenac 
within 60 minutes. But batch BF2 released over 80% of 
diclofenac in 30 minutes and about 95% of diclofenac in 45 
minutes. Batch BF2 can be regarded as the optimized batch 
having released over 80% in 30 minutes, had percentage 
diclofenac content of 92.3%, and emulsification time of 120 
seconds (2 minutes). 
 The SMEDDS system showed high viscosity especially 
for batches BF1, BF2 and BF3 which are batches with the 
highest concentration of coconut oil. The high viscosity and 
very low conductivity of the SMEDDS system indicates that 
it is a water-in-oil emulsion system (Pooja et al., 2011; Ajeet 
et al., 2009 and Cho et al., 2008).  
 The in vitro Self-emulsification efficiency of the 
formulations determined by self-emulsification 
time and the efficiency of pre-concentrate dispersibility when 
it is exposed to aqueous dilution was visually assessed and 
defined using the grade A to E grading scale system reported 
by previous researcher (Khoo et al., 1998 and Balakumar et 
al., 2013). The SMEDDS in this study fell into grade C (Fine 
milky emulsion that formed within 2 min). An emulsification 
time of 2 min is often recommended for such systems 
 The overall micromeritic properties of diclofenac-loaded 
SMEDDS was poor and this may be due to the wet granulation 
technique employed in preparing the self-emulsifying 
granules using lactose as adsorbent powder or carrier, and the 
liquid SEDDS as binder. The adsorption capacity of lactose is 
low and granulation with SEDDS produces a broader size 
distribution and aggregation is difficult to control when 
compared with granulation procedure where water is 
employed as granulating agent (Franceschinis et al., 2015; 
Nikolakakis and Partheniadis, 2017). 
 In conclusion, the study has revealed that coconut oil in 
combination with tween 80, polyethelene glycol 400, 
propylene glycol can be used in the preparation of Self-
microemulsifying drug delivery system for the delivery of 
diclofenac. The coconut oil based SMEDDS of diclofenac 
sodium showed rapid emulsification. 
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